Nonalcoholic fatty liver disease: a feature of the metabolic syndrome - PubMed (original) (raw)
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
G Marchesini et al. Diabetes. 2001 Aug.
Abstract
Insulin sensitivity (euglycemic clamp, insulin infusion rate: 40 mU. m(-2). min(-1)) was studied in 30 subjects with biopsy-proven nonalcoholic fatty liver disease (NAFLD), normal glucose tolerance, and a BMI <30 kg/m(2). Of those 30 subjects, 9 had pure fatty liver and 21 had evidence of steatohepatitis. In addition, 10 patients with type 2 diabetes under good metabolic control and 10 healthy subjects were studied. Most NAFLD patients had central fat accumulation, increased triglycerides and uric acid, and low HDL cholesterol, irrespective of BMI. Glucose disposal during the clamp was reduced by nearly 50% in NAFLD patients, as well as in patients with normal body weight, to an extent similar to that of the type 2 diabetic patients. Basal free fatty acids were increased, whereas insulin-mediated suppression of lipolysis was less effective (-69% in NAFLD vs. -84% in control subjects; P = 0.003). Postabsorptive hepatic glucose production (HGP), measured by [6,6-(2)H(2)]glucose, was normal. In response to insulin infusion, HGP decreased by only 63% of basal in NAFLD vs. 84% in control subjects (P = 0.002). Compared with type 2 diabetic patients, NAFLD patients were characterized by lower basal HGP, but with similarly reduced insulin-mediated suppression of HGP. There was laboratory evidence of iron overload in many NAFLD patients, but clinical, histological, and biochemical data (including insulin sensitivity) were not correlated with iron status. Four subjects were heterozygous for mutation His63Asp of the HFE gene of familiar hemochromatosis. We concluded that NAFLD, in the presence of normoglycemia and normal or moderately increased body weight, is characterized by clinical and laboratory data similar to those found in diabetes and obesity. NAFLD may be considered an additional feature of the metabolic syndrome, with specific hepatic insulin resistance.
Similar articles
- Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H. Henriksen JE, et al. Diabetes. 2000 Jul;49(7):1209-18. doi: 10.2337/diabetes.49.7.1209. Diabetes. 2000. PMID: 10909980 - Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
Vaag A, Lehtovirta M, Thye-Rönn P, Groop L; European Group of Insulin Resistance. Vaag A, et al. Diabet Med. 2001 Jul;18(7):533-40. doi: 10.1046/j.1464-5491.2001.00496.x. Diabet Med. 2001. PMID: 11553181 - Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. Kotronen A, et al. Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21. Gastroenterology. 2008. PMID: 18474251 - Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Bugianesi E, et al. Curr Pharm Des. 2010 Jun;16(17):1941-51. doi: 10.2174/138161210791208875. Curr Pharm Des. 2010. PMID: 20370677 Review. - Fatty acids and insulin resistance.
Boden G. Boden G. Diabetes Care. 1996 Apr;19(4):394-5. doi: 10.2337/diacare.19.4.394. Diabetes Care. 1996. PMID: 8729171 Review.
Cited by
- Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians.
Mehta M, Shah J, Joshi U. Mehta M, et al. Cureus. 2024 Oct 3;16(10):e70768. doi: 10.7759/cureus.70768. eCollection 2024 Oct. Cureus. 2024. PMID: 39364176 Free PMC article. Review. - Carotid Intima-Media Thickness in Indian Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and a Meta-Analysis.
Kumar R, Narayan R. Kumar R, et al. Cureus. 2024 Sep 2;16(9):e68439. doi: 10.7759/cureus.68439. eCollection 2024 Sep. Cureus. 2024. PMID: 39360047 Free PMC article. Review. - Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing's syndrome.
Yu P, Yuan H, Li X, Chen H. Yu P, et al. Endocrine. 2024 Sep 25. doi: 10.1007/s12020-024-04043-4. Online ahead of print. Endocrine. 2024. PMID: 39320593 - Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis.
Zhang L, Wu HD, Qian YF, Xu HY. Zhang L, et al. World J Clin Cases. 2024 Sep 6;12(25):5749-5760. doi: 10.12998/wjcc.v12.i25.5749. World J Clin Cases. 2024. PMID: 39247728 Free PMC article. - Factors Influencing Liver Abnormalities in Psoriatic Arthritis Patients: A Comprehensive Study.
Ong PS, Tan LK, Mat H, Tohar N, Fathi AM, Kosenin NMA, Naim MNB, Redzuan RF, Rani NIA, Norhisham NA, Sulaiman W. Ong PS, et al. Mediterr J Rheumatol. 2023 Aug 27;35(2):234-240. doi: 10.31138/mjr.050723.fla. eCollection 2024 Jun. Mediterr J Rheumatol. 2023. PMID: 39211017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous